HUT73178A - Pharmaceutical composition containing thymoctonan and azt - Google Patents
Pharmaceutical composition containing thymoctonan and azt Download PDFInfo
- Publication number
- HUT73178A HUT73178A HU9503432A HU9503432A HUT73178A HU T73178 A HUT73178 A HU T73178A HU 9503432 A HU9503432 A HU 9503432A HU 9503432 A HU9503432 A HU 9503432A HU T73178 A HUT73178 A HU T73178A
- Authority
- HU
- Hungary
- Prior art keywords
- hiv
- azt
- thymoctonan
- treatment
- dideoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9403856A GB9403856D0 (en) | 1994-03-01 | 1994-03-01 | Combined treatment of human retroviral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9503432D0 HU9503432D0 (en) | 1996-01-29 |
| HUT73178A true HUT73178A (en) | 1996-06-28 |
Family
ID=10751061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9503432A HUT73178A (en) | 1994-03-01 | 1995-02-23 | Pharmaceutical composition containing thymoctonan and azt |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0696202A1 (fi) |
| JP (1) | JPH08509993A (fi) |
| KR (1) | KR960701652A (fi) |
| AU (1) | AU1759295A (fi) |
| CA (1) | CA2160248A1 (fi) |
| FI (1) | FI955181A0 (fi) |
| GB (1) | GB9403856D0 (fi) |
| HU (1) | HUT73178A (fi) |
| IL (1) | IL112803A0 (fi) |
| MX (1) | MX9504565A (fi) |
| NO (1) | NO954171D0 (fi) |
| PL (1) | PL311340A1 (fi) |
| WO (1) | WO1995023610A1 (fi) |
| ZA (1) | ZA951654B (fi) |
-
1994
- 1994-03-01 GB GB9403856A patent/GB9403856D0/en active Pending
-
1995
- 1995-02-23 MX MX9504565A patent/MX9504565A/es unknown
- 1995-02-23 PL PL95311340A patent/PL311340A1/xx unknown
- 1995-02-23 EP EP95910515A patent/EP0696202A1/en not_active Withdrawn
- 1995-02-23 HU HU9503432A patent/HUT73178A/hu unknown
- 1995-02-23 JP JP7522672A patent/JPH08509993A/ja active Pending
- 1995-02-23 KR KR1019950704771A patent/KR960701652A/ko not_active Application Discontinuation
- 1995-02-23 CA CA002160248A patent/CA2160248A1/en not_active Abandoned
- 1995-02-23 WO PCT/EP1995/000653 patent/WO1995023610A1/en not_active Application Discontinuation
- 1995-02-23 AU AU17592/95A patent/AU1759295A/en not_active Abandoned
- 1995-02-27 IL IL11280395A patent/IL112803A0/xx unknown
- 1995-02-28 ZA ZA951654A patent/ZA951654B/xx unknown
- 1995-10-19 NO NO954171A patent/NO954171D0/no unknown
- 1995-10-30 FI FI955181A patent/FI955181A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA951654B (en) | 1995-12-08 |
| HU9503432D0 (en) | 1996-01-29 |
| FI955181A (fi) | 1995-10-30 |
| JPH08509993A (ja) | 1996-10-22 |
| NO954171L (no) | 1995-10-19 |
| FI955181A0 (fi) | 1995-10-30 |
| WO1995023610A1 (en) | 1995-09-08 |
| IL112803A0 (en) | 1995-05-26 |
| EP0696202A1 (en) | 1996-02-14 |
| MX9504565A (es) | 1997-05-31 |
| KR960701652A (ko) | 1996-03-28 |
| AU1759295A (en) | 1995-09-18 |
| GB9403856D0 (en) | 1994-04-20 |
| PL311340A1 (en) | 1996-02-05 |
| CA2160248A1 (en) | 1995-09-08 |
| NO954171D0 (no) | 1995-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2656938B2 (ja) | ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物 | |
| Noble et al. | Saquinavir: a review of its pharmacology and clinical potential in the management of HIV infection | |
| Conteas et al. | Therapy for human gastrointestinal microsporidiosis. | |
| ES2543066T3 (es) | Combinación terapéutica que comprende dolutegravir, abacavir y lamivudina | |
| RU2368380C2 (ru) | Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы | |
| WO1995017899A2 (en) | Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread | |
| Merigan | Treatment of AIDS with combinations of antiretroviral agents | |
| JPH07267874A (ja) | Ｈｉｖ感染に対する組合せ化学療法 | |
| TOCHIKURA et al. | Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan | |
| JP2004538334A (ja) | Ｈｉｖ感染の治療に使用される薬剤とその成分と使用法 | |
| US11191763B2 (en) | HIV post-exposure prophylaxis | |
| JP2001520657A (ja) | Ｈｉｖ感染用コンビネーションセラピー | |
| HUT73178A (en) | Pharmaceutical composition containing thymoctonan and azt | |
| KR19980701856A (ko) | 사람 면역결핍 바이러스 프로테아제 억제제인 인디나비르 및 역전사효소 억제제인 β-Ｌ-2',3'-디데옥시-3'-티아사이티딘, 및 임의의 지도부딘, 디데옥시이노신 또는 디데옥시사이티딘을 사용한 사람 면역결핍 바이러스 감염의 배합 치료 | |
| RU2126266C1 (ru) | Способ ингибирования ретровирусной инфекции (варианты), ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора | |
| HUT77720A (hu) | HIV-ellenes, zidovudint, lamivudint és loviridint tartalmazó kombinációs gyógyszerkészítmény és eljárás előállítására | |
| Acosta et al. | Agents for treating human immunodeficiency virus infection | |
| JPH01313433A (ja) | 抗ｈｉｖ剤 | |
| CA2502625A1 (en) | Dioxolane thymine and combinations for use against resistant strains of hiv | |
| GB2400552A (en) | Pharmaceutical combinations for treating viral infections | |
| EP0684818B1 (en) | Method of reversing resistance of hiv-1 strains to zidovudine | |
| Chirigos et al. | Imexon and biological response modifiers in murine models of AIDS | |
| Pomerantz et al. | Therapy of human immunodeficiency virus infections | |
| Youle et al. | 8 The treatment of HIV disease | |
| Lange et al. | Antiretroviral treatment: state of the art and future directions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFC4 | Cancellation of temporary protection due to refusal |